Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of LEO 90105 in Japanese Psoriasis
NCT01768013Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Jul 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of calcipotriol + betamethasone in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Jul 2012; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT01768013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01768013.